Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?
作者信息
Gupta R, Raviglione M C, Espinal M A
机构信息
World Health Organization.
出版信息
Int J Tuberc Lung Dis. 2001 Dec;5(12):1078-9.
PMID:11769764
Abstract
摘要
Zotero 插件